Dov Shiffman

4.1k total citations
70 papers, 3.1k citations indexed

About

Dov Shiffman is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Dov Shiffman has authored 70 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Surgery and 19 papers in Genetics. Recurrent topics in Dov Shiffman's work include Lipoproteins and Cardiovascular Health (17 papers), Genetic Associations and Epidemiology (14 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers). Dov Shiffman is often cited by papers focused on Lipoproteins and Cardiovascular Health (17 papers), Genetic Associations and Epidemiology (14 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers). Dov Shiffman collaborates with scholars based in United States, Sweden and Canada. Dov Shiffman's co-authors include James J. Devlin, Charles M. Rowland, Judy Z. Louie, Joseph J. Catanese, Olle Melander, May M. Luke, Olga A. Iakoubova, Eric E. Brooks, Mary J. Malloy and John P. Kane and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Dov Shiffman

70 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dov Shiffman United States 33 996 881 643 632 453 70 3.1k
James J. Devlin United States 34 1.6k 1.6× 1.2k 1.3× 920 1.4× 1.2k 1.8× 488 1.1× 89 4.6k
Bryan J. Barratt United Kingdom 23 826 0.8× 754 0.9× 743 1.2× 1.3k 2.0× 423 0.9× 35 3.0k
Michael P. Caulfield United States 31 1.4k 1.4× 841 1.0× 473 0.7× 299 0.5× 1.0k 2.3× 89 3.6k
N Yamada Japan 36 901 0.9× 925 1.0× 716 1.1× 271 0.4× 1.1k 2.4× 73 3.1k
Miguel Pocovı́ Spain 40 1.1k 1.1× 1.8k 2.0× 684 1.1× 286 0.5× 984 2.2× 167 4.4k
Lita A. Freeman United States 35 1.3k 1.4× 1.5k 1.6× 428 0.7× 182 0.3× 783 1.7× 73 3.2k
Scott Turner United States 39 1.7k 1.7× 905 1.0× 225 0.3× 279 0.4× 784 1.7× 122 4.8k
David Masson France 38 1.2k 1.2× 1.4k 1.6× 623 1.0× 245 0.4× 859 1.9× 162 4.5k
Vincent Maher United States 33 1.5k 1.5× 804 0.9× 507 0.8× 213 0.3× 468 1.0× 103 3.1k
Hitoshi Kohno Japan 40 1.2k 1.2× 1.5k 1.7× 187 0.3× 614 1.0× 784 1.7× 135 5.2k

Countries citing papers authored by Dov Shiffman

Since Specialization
Citations

This map shows the geographic impact of Dov Shiffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dov Shiffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dov Shiffman more than expected).

Fields of papers citing papers by Dov Shiffman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dov Shiffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dov Shiffman. The network helps show where Dov Shiffman may publish in the future.

Co-authorship network of co-authors of Dov Shiffman

This figure shows the co-authorship network connecting the top 25 collaborators of Dov Shiffman. A scholar is included among the top collaborators of Dov Shiffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dov Shiffman. Dov Shiffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Louie, Judy Z., Dov Shiffman, Charles M. Rowland, et al.. (2024). Predictors of lack of glycemic control in persons with type 2 diabetes. SHILAP Revista de lepidopterología. 10(1). 1 indexed citations
2.
Louie, Judy Z., Dov Shiffman, Michael J. McPhaul, & Olle Melander. (2023). Insulin resistance probability score and incident cardiovascular disease. Journal of Internal Medicine. 294(4). 531–535. 18 indexed citations
3.
Rooney, Mary R., Natalie Daya, Aaron Leong, et al.. (2023). Prognostic value of insulin resistance and hyperglycemia biomarkers for long-term risks of cardiometabolic outcomes. Journal of Diabetes and its Complications. 37(9). 108583–108583. 1 indexed citations
4.
Bril, Fernando, Michael J. McPhaul, Michael P. Caulfield, et al.. (2019). Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes. Diabetes Care. 43(2). 290–297. 126 indexed citations
5.
Jelencsics, Kíra, Dov Shiffman, Guillaume Paré, et al.. (2015). Genome-wide studies to identify risk factors for kidney disease with a focus on patients with diabetes. Nephrology Dialysis Transplantation. 30(suppl 4). iv26–iv34. 41 indexed citations
6.
Shiffman, Dov, Marco Pérez, Lance A. Bare, et al.. (2015). Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis. BMC Cardiovascular Disorders. 15(1). 104–104. 4 indexed citations
7.
Rowland, Charles M., Clive R. Pullinger, May M. Luke, et al.. (2014). Lipoprotein (a), LPA Ile4399Met, and Fibrin Clot Properties. Thrombosis Research. 133(5). 863–867. 27 indexed citations
8.
Shiffman, Dov, Guillaume Paré, Rainer Oberbauer, et al.. (2014). A Gene Variant in CERS2 Is Associated with Rate of Increase in Albuminuria in Patients with Diabetes from ONTARGET and TRANSCEND. PLoS ONE. 9(9). e106631–e106631. 30 indexed citations
9.
Li, Yonghong, Dov Shiffman, & Rainer Oberbauer. (2011). Analysis of Single Nucleotide Polymorphisms in Case–Control Studies. Methods in molecular biology. 719. 219–234. 1 indexed citations
10.
Shiffman, Dov, Ellen S. O’Meara, Charles M. Rowland, et al.. (2011). The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study. BMC Cardiovascular Disorders. 11(1). 10–10. 11 indexed citations
11.
Paré, Guillaume, Paul M. Ridker, Lynda Rose, et al.. (2011). Genome-Wide Association Analysis of Soluble ICAM-1 Concentration Reveals Novel Associations at the NFKBIK, PNPLA3, RELA, and SH2B3 Loci. PLoS Genetics. 7(4). e1001374–e1001374. 72 indexed citations
12.
Shiffman, Dov, Judy Z. Louie, Charles M. Rowland, et al.. (2010). Single variants can explain the association between coronary heart disease and haplotypes in the apolipoprotein(a) locus. Atherosclerosis. 212(1). 193–196. 10 indexed citations
13.
Shiffman, Dov, Daniel I. Chasman, Robert Y.L. Zee, et al.. (2008). A Kinesin Family Member 6 Variant Is Associated With Coronary Heart Disease in the Women’s Health Study. Journal of the American College of Cardiology. 51(4). 444–448. 65 indexed citations
14.
Bare, Lance A., Alanna C. Morrison, Charles M. Rowland, et al.. (2007). Five common gene variants identify elevated genetic risk for coronary heart disease. Genetics in Medicine. 9(10). 682–689. 75 indexed citations
15.
Wang, Yulei, Cátálin Bárbácioru, Dov Shiffman, et al.. (2007). Gene Expression Signature in Peripheral Blood Detects Thoracic Aortic Aneurysm. PLoS ONE. 2(10). e1050–e1050. 72 indexed citations
16.
Gupta, Sunita, et al.. (2003). The Tumor Suppressor Interferon Regulatory Factor 1 Interferes with SP1 Activation to Repress the Human CDK2 Promoter. Journal of Biological Chemistry. 278(29). 26589–26596. 57 indexed citations
17.
Shiffman, Dov, Thomas Mikita, Julie Tai, et al.. (2000). Large Scale Gene Expression Analysis of Cholesterol-loaded Macrophages. Journal of Biological Chemistry. 275(48). 37324–37332. 109 indexed citations
18.
Brooks, Alan R., Dov Shiffman, Christine Chan, Eric E. Brooks, & Peter G. Milner. (1996). Functional Analysis of the Human Cyclin D2 and Cyclin D3 Promoters. Journal of Biological Chemistry. 271(15). 9090–9099. 109 indexed citations
19.
20.
Shiffman, Dov, Moshe Mevarech, Susan E. Jensen, Gerald Cohen, & Yair Aharonowitz. (1988). Cloning and comparative sequence analysis of the gene coding for isopenicillin N synthase in Streptomyces. Molecular and General Genetics MGG. 214(3). 562–569. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James J. Devlin Breakdown of academic impact, for papers by Bryan J. Barratt Breakdown of academic impact, for papers by Michael P. Caulfield Breakdown of academic impact, for papers by N Yamada Breakdown of academic impact, for papers by Miguel Pocovı́ Breakdown of academic impact, for papers by Lita A. Freeman Breakdown of academic impact, for papers by Scott Turner Breakdown of academic impact, for papers by David Masson Breakdown of academic impact, for papers by Vincent Maher Breakdown of academic impact, for papers by Hitoshi Kohno
Rankless by CCL
2026